UP
Upstream Bio, Inc. (UPB)
NASDAQ·Healthcare·Biotechnology
$5.18
-5.83%
Mkt Cap $290.60M
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (4 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+189.6%
Consensus $15.00 vs current $5.18
NASDAQ·Healthcare·Biotechnology
$5.18
-5.83%
Mkt Cap $290.60M
Buy
3
Hold
2
Sell
0
Price Target (4 analysts)
$15.00
Range $15.00 – $15.00
+189.6%
Consensus $15.00 vs current $5.18